Neupgen is a medication used to stimulate the bone marrow to produce white blood cells, especially after chemotherapy sessions that lead to a decrease in immunity. It contains a substance that mimics a natural protein in the body responsible for activating the growth of blood cells. It is given by subcutaneous or intravenous injection according to the doctor's instructions. Its effect begins within a few days, which helps reduce the risk of infection.
Neupgen is often used in patients at risk of a severe decrease in white blood cells to maintain the continuity of treatment without delay. It may cause bone pain or redness at the injection site, but these gradually disappear, and the medication remains an important option for supporting immunity during critical periods.